Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q7RTS9: Variant p.Glu87Lys

Dymeclin
Gene: DYM
Feedback?
Variant information Variant position: help 87 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 87 (E87K, p.Glu87Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SMC1; does not affect protein localization. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 87 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 669 The length of the canonical sequence.
Location on the sequence: help NNPRTGNLGALIKVFLSRTK E LKLSAECQNHIFIWQTHNAL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         NNPRTGNLGALIKVFLSR---------------------TKELKLSAECQNHIFIWQTH--NAL

Mouse                         NNPRTGNLAALTKVFLSR---------------------TR

Rat                           NNPRTGNLAALTKVFLAR---------------------TR

Chicken                       KNPRTGNLGSLIKVFLSR---------------------TK

Xenopus laevis                NNPRTGNLGALIRVFLSR---------------------TK

Xenopus tropicalis            NNPRTGNLGALIRVFLSR---------------------TK

Drosophila                    NNLKTGNFGSLVTVFLEK---------------------TS

Slime mold                    NNLKTKNFNRILMHFINKLNLFNQQLITISESMKKNKGSKQ
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 669 Dymeclin
Alternative sequence 66 – 255 Missing. In isoform 2.



Literature citations
The gene responsible for Dyggve-Melchior-Clausen syndrome encodes a novel peripheral membrane protein dynamically associated with the Golgi apparatus.
Dimitrov A.; Paupe V.; Gueudry C.; Sibarita J.-B.; Raposo G.; Vielemeyer O.; Gilbert T.; Csaba Z.; Attie-Bitach T.; Cormier-Daire V.; Gressens P.; Rustin P.; Perez F.; El Ghouzzi V.;
Hum. Mol. Genet. 18:440-453(2009)
Cited for: TISSUE SPECIFICITY; SUBCELLULAR LOCATION; MYRISTOYLATION AT GLY-2; MUTAGENESIS OF GLY-2; CHARACTERIZATION OF VARIANT SMC1 LYS-87; CHARACTERIZATION OF VARIANT DMC TYR-469; Mental retardation and abnormal skeletal development (Dyggve-Melchior-Clausen dysplasia) due to mutations in a novel, evolutionarily conserved gene.
Cohn D.H.; Ehtesham N.; Krakow D.; Unger S.; Shanske A.; Reinker K.; Powell B.R.; Rimoin D.L.;
Am. J. Hum. Genet. 72:419-428(2003)
Cited for: VARIANT DMC TYR-469; VARIANT SMC1 LYS-87;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.